Additionally, the high tumor tissue levels of IL-33 correlated with a favorable prognosis in patients with either iCCA or pCCA [144] while granulocyte colony-stimulating factor (G-CSF) were suggested as a prognostic biomarker to predict tumor recurrence after resection [145,146]. The gene discussed is IL33; the disease is neoplasm.